Secondly, we employed drug target MR and network MR analysis to demonstrate the mediation effect of HDL-C in CETP on CD, and the causal effect of the PCSK9 inhibitor on IBD, UC, and CD. The gene discussed is PCSK9; the disease is inflammatory bowel disease.